DIA381.62-9.74 -2.49%
SPX5,158.20-124.50 -2.36%
IXIC15,870.90-415.55 -2.55%

Earnings Scheduled For March 27, 2025

Benzinga·03/27/2025 08:32:15
Listen to the news

Companies Reporting Before The Bell

• Tsakos Energy Navigation (NYSE:TEN) is projected to report quarterly earnings at $0.40 per share on revenue of $154.43 million.

• Worksport (NASDAQ:WKSP) is projected to report quarterly loss at $1.40 per share on revenue of $2.90 million.

• PDS Biotechnology (NASDAQ:PDSB) is projected to report earnings for its fourth quarter.

• FitLife Brands (NASDAQ:FTLF) is estimated to report quarterly earnings at $0.20 per share on revenue of $14.95 million.

• ADC Therapeutics (NYSE:ADCT) is expected to report quarterly loss at $0.35 per share on revenue of $19.67 million.

• Telesat (NASDAQ:TSAT) is expected to report earnings for its fourth quarter.

• Acumen Pharmaceuticals (NASDAQ:ABOS) is expected to report earnings for its fourth quarter.

• Bitfarms (NASDAQ:BITF) is estimated to report quarterly loss at $0.04 per share on revenue of $53.82 million.

• Winnebago Industries (NYSE:WGO) is expected to report quarterly earnings at $0.19 per share on revenue of $608.95 million.

• BK Technologies (AMEX:BKTI) is estimated to report quarterly earnings at $0.35 per share on revenue of $16.80 million.

• Edap TMS (NASDAQ:EDAP) is estimated to report quarterly loss at $0.11 per share on revenue of $20.83 million.

• TriSalus Life Sciences (NASDAQ:TLSI) is likely to report quarterly loss at $0.35 per share on revenue of $8.24 million.

• BIO-key Intl (NASDAQ:BKYI) is likely to report quarterly loss at $0.35 per share on revenue of $2.29 million.

• Icecure Medical (NASDAQ:ICCM) is expected to report quarterly loss at $0.07 per share on revenue of $1.07 million.

• Jiayin Gr (NASDAQ:JFIN) is likely to report earnings for its fourth quarter.

• Ascentage Pharma Group (NASDAQ:AAPG) is projected to report earnings for its fourth quarter.

• Urban One (NASDAQ:UONEK) is estimated to report earnings for its fourth quarter.

• Urban One (NASDAQ:UONE) is projected to report earnings for its fourth quarter.

• TD Synnex (NYSE:SNX) is likely to report quarterly earnings at $2.91 per share on revenue of $14.79 billion.

• Sachem Cap (AMEX:SACH) is projected to report quarterly loss at $0.46 per share on revenue of $14.49 million.

• Ermenegildo Zegna (NYSE:ZGN) is likely to report earnings for its Fiscal Year 2024.

• Innate Pharma (NASDAQ:IPHA) is projected to report earnings for its Fiscal Year 2024.

Companies Reporting After The Bell

• Dolphin Entertainment (NASDAQ:DLPN) is likely to report quarterly earnings at $0.04 per share on revenue of $13.52 million.

• Relmada Therapeutics (NASDAQ:RLMD) is projected to report earnings for its fourth quarter.

• Draganfly (NASDAQ:DPRO) is projected to report quarterly loss at $0.66 per share on revenue of $1.45 million.

• Gevo (NASDAQ:GEVO) is projected to report quarterly loss at $0.09 per share on revenue of $3.85 million.

• SeaStar Medical Holding (NASDAQ:ICU) is likely to report earnings for its fourth quarter.

• INmune Bio (NASDAQ:INMB) is projected to report earnings for its fourth quarter.

• TMC Metals (NASDAQ:TMC) is estimated to report earnings for its fourth quarter.

• Strata Skin Sciences (NASDAQ:SSKN) is expected to report quarterly loss at $0.40 per share on revenue of $9.03 million.

• IZEA Worldwide (NASDAQ:IZEA) is expected to report quarterly loss at $0.08 per share on revenue of $13.00 million.

• Yxt.Com Group Holding (NASDAQ:YXT) is expected to report earnings for its fourth quarter.

• TSS (NASDAQ:TSSI) is expected to report earnings for its fourth quarter.

• BioRestorative Therapies (NASDAQ:BRTX) is likely to report quarterly loss at $0.27 per share on revenue of $475 thousand.

• Direct Digital Holdings (NASDAQ:DRCT) is likely to report quarterly loss at $0.67 per share on revenue of $12.31 million.

• Faraday Future (NASDAQ:FFAI) is expected to report earnings for its fourth quarter.

• 374Water (NASDAQ:SCWO) is likely to report quarterly loss at $0.02 per share on revenue of $100 thousand.

• Lantern Pharma (NASDAQ:LTRN) is estimated to report earnings for its fourth quarter.

• Geovax Labs (NASDAQ:GOVX) is projected to report quarterly loss at $0.95 per share on revenue of $920 thousand.

• Unusual Machines (AMEX:UMAC) is likely to report earnings for its fourth quarter.

• BioAtla (NASDAQ:BCAB) is expected to report earnings for its fourth quarter.

• Plus Therapeutics (NASDAQ:PSTV) is projected to report quarterly loss at $0.51 per share on revenue of $1.19 million.

• VirTra (NASDAQ:VTSI) is projected to report quarterly earnings at $0.07 per share on revenue of $8.09 million.

• Forian (NASDAQ:FORA) is estimated to report quarterly earnings at $0.02 per share on revenue of $5.37 million.

• Spero Therapeutics (NASDAQ:SPRO) is likely to report quarterly loss at $0.31 per share on revenue of $6.20 million.

• Beachbody Co (NYSE:BODI) is likely to report quarterly loss at $1.52 per share on revenue of $81.71 million.

• Stardust Power (NASDAQ:SDST) is expected to report earnings for its fourth quarter.

• Valhi (NYSE:VHI) is expected to report quarterly earnings at $0.03 per share on revenue of $19.48 million.

• Nutex Health (NASDAQ:NUTX) is projected to report quarterly earnings at $0.00 per share on revenue of $81.13 million.

• Iridex (NASDAQ:IRIX) is projected to report quarterly loss at $0.05 per share on revenue of $12.80 million.

• AAR (NYSE:AIR) is projected to report quarterly earnings at $0.96 per share on revenue of $679.95 million.

• Oxford Industries (NYSE:OXM) is expected to report quarterly earnings at $1.28 per share on revenue of $383.94 million.

• P3 Health Partners (NASDAQ:PIII) is expected to report quarterly loss at $0.17 per share on revenue of $385.80 million.

• Co-Diagnostics (NASDAQ:CODX) is likely to report quarterly loss at $0.34 per share on revenue of $375 thousand.

• Argan (NYSE:AGX) is estimated to report quarterly earnings at $1.11 per share on revenue of $212.05 million.

• HireQuest (NASDAQ:HQI) is likely to report quarterly earnings at $0.19 per share on revenue of $9.30 million.

• Lululemon Athletica (NASDAQ:LULU) is expected to report quarterly earnings at $5.65 per share on revenue of $3.52 billion.

• Clearside Biomedical (NASDAQ:CLSD) is likely to report quarterly loss at $0.11 per share on revenue of $294 thousand.

• KULR Tech Gr (AMEX:KULR) is estimated to report quarterly loss at $0.02 per share on revenue of $2.87 million.

• Blaize Holdings (NASDAQ:BZAI) is expected to report earnings for its fourth quarter.

• Sky Harbour Group (NYSE:SKYH) is expected to report quarterly loss at $0.06 per share on revenue of $4.15 million.

• Better Choice Co (AMEX:BTTR) is likely to report earnings for its fourth quarter.

• Pulse Biosciences (NASDAQ:PLSE) is likely to report earnings for its fourth quarter.

• Braze (NASDAQ:BRZE) is expected to report quarterly earnings at $0.04 per share on revenue of $155.25 million.

• Lulus Fashion Lounge (NASDAQ:LVLU) is likely to report quarterly loss at $0.14 per share on revenue of $68.43 million.

• Spectral AI (NASDAQ:MDAI) is expected to report quarterly loss at $0.14 per share on revenue of $6.83 million.

• Barfresh Food Group (NASDAQ:BRFH) is expected to report quarterly loss at $0.01 per share on revenue of $4.17 million.

• Abacus Global Management (NASDAQ:ABL) is expected to report quarterly earnings at $0.14 per share on revenue of $30.18 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.